Literature DB >> 16831689

Assessing the impact of HBV NAT on window period reduction and residual risk.

Steven H Kleinman1, Michael P Busch.   

Abstract

Mesh：

Year:  2006        PMID： 16831689     DOI： 10.1016/s1386-6532(06)80005-3

Source DB:  PubMed          Journal:  J Clin Virol        ISSN： 1386-6532            Impact factor:   3.168


× No keyword cloud information.
  21 in total

Review 1.  The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Med Microbiol Immunol       Date:  2010-05-11       Impact factor: 3.402

2.  PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.

Authors:  Debbie L Seem; Ingi Lee; Craig A Umscheid; Matthew J Kuehnert
Journal:  Public Health Rep       Date:  2013-07       Impact factor: 2.792

Review 3.  Diagnostic algorithm for HBV safe transfusion.

Authors:  Jean-Pierre Allain; Daniel Candotti
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

4.  Virus NAT for HIV, HBV, and HCV in Post-Mortal Blood Specimens over 48 h after Death of Infected Patients - First Results.

Authors:  Thomas Meyer; Susanne Polywka; Birgit Wulff; Carolin Edler; Ann Sophie Schröder; Ina Wilkemeyer; Ulrich Kalus; Axel Pruss
Journal:  Transfus Med Hemother       Date:  2012-11-19       Impact factor: 3.747

5.  Prevalence, incidence and residual risk of transfusion-transmitted hepatitis B virus infection in Italy from 2009 to 2018.

Authors:  Claudio Velati; Luisa Romanò; Ilaria Pati; Giuseppe Marano; Vanessa Piccinini; Liviana Catalano; Simonetta Pupella; Stefania Vaglio; Eva Veropalumbo; Francesca Masiello; Giulio Pisani; Giuliano Grazzini; Alessandro Zanetti; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2019-12-11       Impact factor: 3.443

Review 6.  Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing.

Authors:  Antonella Esposito; Chiara Sabia; Carmela Iannone; Giovanni F Nicoletti; Linda Sommese; Claudio Napoli
Journal:  Transfus Med Hemother       Date:  2017-05-05       Impact factor: 3.747

Review 7.  Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Mol Biol Rep       Date:  2020-12-09       Impact factor: 2.316

Review 8.  Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality.

Authors:  Eleftherios C Vamvakas; Morris A Blajchman
Journal:  Transfus Med Rev       Date:  2010-04

9.  Surface antigen-negative hepatitis B virus infection in Dutch blood donors.

Authors:  R W Lieshout-Krikke; M W A Molenaar-de Backer; P van Swieten; H L Zaaijer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-13       Impact factor: 3.267

Review 10.  Opportunistic infections--coming to the limits of immunosuppression?

Authors:  Jay A Fishman
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.